Overview

Alzheimer and Sleep

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) without Alzheimer's medication.

Phase:

Phase 1

Details

Lead Sponsor:

University Hospital, Clermont-Ferrand

Collaborator:

Janssen-Cilag Farmaceutica Ltda.

Treatments:

Donepezil
Galantamine